Andrea S. Blevins Primeau, PhD, MBA

Andrea S. Blevins Primeau, PhD, MBA, is a freelance medical writer and editor based in central Pennsylvania. She enjoys writing about a variety of topics including oncology, cardiovascular disease, and autoimmune disorders. Previously, she conducted research investigating the role of pharmacogenetics on the efficacy of oncologic therapies.

Most Recent Articles by Andrea S. Blevins Primeau, PhD, MBA

Aspartame and Cancer

Aspartame and Cancer

By

Despite controversy, many studies have found no significant association between aspartame consumption and the incidence of different types of solid and hematologic malignancies.

Vitamin A and Cancer

Vitamin A and Cancer

By

Vitamin A supplementation likely does not reduce chemotherapy efficacy and, for many patients, is unlikely to cause harm.

In Focus: Ponatinib for Chronic Myeloid Leukemia

In Focus: Ponatinib for Chronic Myeloid Leukemia

By

Ponatinib is highly effective among patients with CML, but the optimal dose is still being determined. Current trials are evaluating an initial dose of 30 mg, with a reduction to 15 mg when a response is achieved.

Vitamin C and Cancer

Vitamin C and Cancer

By

Though some studies reported improvements in clinical outcomes and quality of life with vitamin C treatment, these findings have not been replicated in randomized controlled studies.

Drug-herb and Drug-drug Interactions in Oncology

Drug-herb and Drug-drug Interactions in Oncology

By

Mixed data highlight the need for researchers to conduct studies to understand the clinical, rather than just theoretical, risks of HDIs and DDIs.

More Articles by Andrea S. Blevins Primeau, PhD, MBA

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters